Download PDF
Zeitschrift für Komplementärmedizin 2025; 17(03): 12-18
DOI: 10.1055/a-2592-1639
Wissen
Phytotherapie

Phytotherapie bei Herzrhythmusstörungen

Peter W. Gündling
› Further Information
   Permissions and Reprints

Summary

Erkrankungen des Herzens und der Blutgefäße stellen weltweit die häufigste Todesursache dar und werden oft durch Risikofaktoren wie Bluthochdruck, Arteriosklerose und Herzrhythmusstörungen verursacht. Neben der medikamentösen Standardtherapie stehen einige wirkungsvolle Phytotherapeutika zur Verfügung. Der Beitrag fasst wissenschaftliche Studien zu antiarrhythmischen Heilpflanzen zusammen. Zu ihnen gehören vor allem Ginseng, Ginkgo, Knoblauch, Eisenhut sowie Weißdorn.

Keywords

Phytotherapie - Herzrhythmusstörungen - Roter Fingerhut - Weißdorn - Crataegusextrakt WS 1442


Publication History

Article published online:
10 June 2025

© 2025. Thieme. All rights reserved.

© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co.
KG

 

  • Literatur

  • 1 Ahn J-Y, Chu H, Leem J. et al Effectiveness and safety of traditional herbal medicine on cardiac arrhythmic condition. A systematic review and meta-analysis of randomized control clinical trial. Medicine 2024; 103: e38441
    PubMedSearch in Google Scholar
  • 2 Nattel S, Harada M. Atrial remodeling and atrial fibrillation: Recent advances and translational perspectives. J Am Coll Cardiol 2014; 63 (22) 2335-2345
    PubMedSearch in Google Scholar
  • 3 Schilcher H, Kammerer S, Wegener T. Leitfaden Phytotherapie. 5. Aufl. München: Elsevier, Urban & Fischer; 2021
    Search in Google Scholar
  • 4 Xing B-N, Jin S-S, Wang H. et al New diterpenoid alkaloids from Aconitum coreanum and their anti-arrhythmic effects on cardiac sodium current. Fitoterapia 2014; 94: 120-126
    PubMedSearch in Google Scholar
  • 5 Hiller K, Melzig MF. Lexikon der Arzneipflanzen und Drogen. Heidelberg: Spektrum; 2003
    Search in Google Scholar
  • 6 Fatehi M, Saleh TM, Fatehi-Hassanabad Z. et al A pharmacological study on Berberis vulgaris fruit extract. J Ethnopharmacol 2005; 102 (01) 46-52
    PubMedSearch in Google Scholar
  • 7 Chen B, Cai J, Song L-S. et al Effects of ginkgo biloba extract on cation currents in rat ventricular myocytes. Life Sciences 2005; 76 (10) 1111-1121
    PubMedSearch in Google Scholar
  • 8 Kandiah N, Chan YF, Chen C. et al Strategies for the use of Ginkgo biloba extract, EGb 761, in the treatment and management of mild cognitive impairment in Asia: Expert consensus. CNS Neurosci Ther 2021; 27: 149-162
    PubMedSearch in Google Scholar
  • 9 Peters H, Kieser M, Hölscher U.. Demonstration of the efficacy of Ginkgo biloba special extract EGb 761 on intermittent claudication – A placebo-controlled, double-blind multicenter trial. VASA 1998; 27: 108-112
    Search in Google Scholar
  • 10 Satoh H. Suppression of pacemaker activity by Ginkgo biloba extract and its main constituent, bilobalide in rat sino-atrial nodal cells. Life Sci 2005; 78 (01) 67-73
    PubMedSearch in Google Scholar
  • 11 Zhao X, Yao H, Yin HL. et al Ginkgo biloba extract and ginkgolide antiarrhythmic potential by targeting hERG and ICa-L channel. J Pharmacol Sci 2013; 123 (04) 318-327
    PubMedSearch in Google Scholar
  • 12 Lee CH, Kim JH. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J Ginseng Res 2014; 38: 161-166
    CrossrefPubMedSearch in Google Scholar
  • 13 Yin H, Liu Z, Li F. et al Ginsenoside-Rg1 enhances angiogenesis and ameliorates ventricular remodeling in a rat model of myocardial infarction. J Molecul Med 2011; 89: 363-375
    Search in Google Scholar
  • 14 Wu W, Zhang XM, Liu PM. et al Effects of Panax notoginseng saponin Rg1 on cardiac electrophysiological properties and ventricular fibrillation threshold in dogs. Zhong Yao Li Xue Bao 1995; 16 (05) 459-463
    Search in Google Scholar
  • 15 Li C, Gao Y, Tian J. et al Sophocarpine administration preserves myocardial function from ischemia-reperfusion in rats via NF-κB inactivation. J Ethnopharmacol 2011; 135 (03) 620-625
    PubMedSearch in Google Scholar
  • 16 Yang Z-F, Li C-Z, Wang W. et al Electrophysiological mechanisms of sophocarpine as a potential antiarrhythmic agent. Acta Pharmacol Sinica 2011; 32 (03) 311-320
    Search in Google Scholar
  • 17 Zhang S, Ma J-H, Zhang P-H. et al Sophocarpine attenuates the Na+-dependent Ca2+ overload induced by anemonia sulcata toxinincreased late sodium current in rabbit ventricular myocytes. J Cardiovasc Pharmacol 2012; 60 (04) 357-366
    PubMedSearch in Google Scholar
  • 18 Aqel MB, Gharaibah MN, Salhab AS. Direct relaxant effects of garlic juice on smooth and cardiac muscles. J Ethnopharmacol 1991; 33 (1–2) 13-19
    PubMedSearch in Google Scholar
  • 19 Ried K, Frank OR, Stocks NP. Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension: A randomised controlled trial. Maturitas 2010; 67 (02) 144-150
    PubMedSearch in Google Scholar
  • 20 Banerjee SK, Dinda AK, Manchanda SC. et al Chronic garlic administration protects rat heart against oxidative stress induced by ischemic reperfusion injury. BMC Pharmacol 2002; 2 (01) 16
    PubMedSearch in Google Scholar
  • 21 Li J, Hu D, Song X. et al The role of biologically active ingredients from natural drug treatments for arrhythmias in different mechanisms. Bio Med Res Int 2017;
    CrossrefPubMedSearch in Google Scholar
  • 22 Holubarsch CJF, Colucci WS, Eha J. Benefit-risk assessment of Crataegus extract WS 1442: An evidence-based review. Am J Carciovasc Drugs 2018; 18: 25-36
    Search in Google Scholar
  • 23 Petry R-J.. Die Lösung des Herzinfarkt-Problems durch g-Strophanthin. Erfahrungsheilkunde 2004; 53 (02) 65-73
    Thieme ConnectSearch in Google Scholar
  • 24 Whayne Jr. TF. Clinical use of Digitalis: A state of the art review. Am J Cardiovasc Drugs 2018; 18 (06) 427-440
    PubMedSearch in Google Scholar
  • 25 https://www.klein-naturarznei.de/kraeuterlexikon/strophantus.html – abgerufen am 27.04.25
  • 26 Ritter M, Melichar K, Strahler S. et al Cardiac and electrophysiological effects of primary and refined extracts from Leonurus cardiaca L. (Ph. Eur.). Planta Med 2010; 76 (06) 572-582
    PubMedSearch in Google Scholar
  • 27 Adams B. Geheimnisse des Herzgespannkrautes gelüftet. Pressemitteilung der Universität Leipzig; 03.08.2007. Im Internet:. https://www.uni-leipzig.de/newsdetail/artikel/geheimnisse-des-herzgespannkrautes-gelueftet-2007-08-03 Stand: 08.05.2025
  • 28 Koshovyi O, Raal A, Kireyev I. et al Phytochemical and psychotropic research of Motherwort (Leonurus cardiaca L.) modified dry extracts. Plants 2021; 10: 230
    PubMedSearch in Google Scholar
  • 29 Martinelli F, Perrone A, Yousefi S. et al Botanical, phytochemical, anti-microbial and pharmaceutical characteristics of Hawthorn (Crataegus monogyna Jacq.), Rosaceae. Molecules 2021; 26: 7266
    PubMedSearch in Google Scholar
  • 30 Brixius K, Frank K, Münch G. et al WS 1442 (Crataegus-Extrakt) wirkt am insuffizienten menschlichen Myokard kontraktionssteigernd. Herz Kreisl 1988; 30: 28-33
    Search in Google Scholar
  • 31 Eggeling T, Regitz-Zagrosek V, Zimmermann A. et al Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure, a pooled analysis of clinical trials. Phytomed 2011; 18 (14) 1214-1219
    Search in Google Scholar
  • 32 Gündling PW.. Weißdorn – Neue Erkenntnisse zu einer alten Heilpflanze. Erfahrungsheilkunde 2017; 66 (04) 36-43
    Search in Google Scholar
  • 33 Holubarsch CJF, Colucci WS, Eha J. Benefit-risk assessment of Crataegus extract WS 1442: An evidence-based review. Am J Cardiovasc Drugs 2018; 18: 25-36
    CrossrefPubMedSearch in Google Scholar
  • 34 Pittler MH, Guo R, Ernst E. Hawthorn extract for treating chronic heart failure. Coch Data Syst Rev 2008; 1: CD005312
    Search in Google Scholar
  • 35 Wegener T, Gündling PW, Holubarsch CJF. et al Bedeutung des Weißdornextrakts in der allgemeinen Praxis – Eine aktuelle Positionierung. MMW Fortschr Med 2018; 160: 1-7
    CrossrefPubMedSearch in Google Scholar
  • 36 Zorniak M, Szydlo B, Krzeminski TF. Crataegus special extract WS 1442: Up-to-date review of experimental and clinical experiences. J Physiol Pharmacol 2017; 68: 521-526
    PubMedSearch in Google Scholar
  • 37 Tauchert M, Ploch M, Hübner WD.. Wirksamkeit des Weiβdorn-Extraktes LI 132 im Vergleich mit Captopril. Münch Med Wochenschr 1994; 136 (l) 27-33
    Search in Google Scholar
  • 38 Schwinger RH, Pietsch M, Frank K. et al Crataegus special extract WS 1442 increases force of contraction in human myocardium cAMP-independently. J Cardiovasc Pharmacol 2000; 35 (05) 700-707
    PubMedSearch in Google Scholar
  • 39 Wegener T. Weißdorn-Extrakt – Aktuelle Erkenntnisse zum Wirkprinzip. Phytokompass 2016; 5: 20-23
    Search in Google Scholar
  • 40 Long SR, Carey RA, Crofoot KM. et al Effect of Hawthorn (Crataegus oxycantha) crude extract and chromatographic fractions on multiple activities in a cultured cardiomyocyte assay. Phytomedicine 2006; 13: 643-650
    PubMedSearch in Google Scholar
  • 41 Nabavi SF. Polyphenolic composition of Crataegus monogyna Jacq.: From chemistry to medical applications. Nutrients 2015; 7: 7708-7728
    PubMedSearch in Google Scholar
  • 42 Krzeminski T, Chatterjee SS. Ischemia and early reperfusion induced arrhythmias: Beneficial effects of an extract of Crataegus oxyacantha L. Pharm Pharmacol Lett 1993; 3: 45-48
    Search in Google Scholar
  • 43 Veveris M, Koch E, Chatterjee SS. Crataegus special extract WS 1442 improves cardiac function and reduces infarct size in a rat model of prolonged coronary ischemia and reperfusion. Life Sci 2004; 74: 1945-1955
    PubMedSearch in Google Scholar
  • 44 Zorniak M, Porc MP, Krzeminski TF. Hawthorn revisited: Time- and dose-dependent cardioprotective action of WS 1442 special extract in the reperfusion-induced arrhythmia model in rats in vivo. J Physiol Pharmacol 2019; 70: 14
    Search in Google Scholar
  • 45 Alp H, Soner BC, Baysal T. et al Protective effects of Hawthorn (Crataegus oxyacantha) extract against digoxin-induced arrhythmias in rats. Anatol J Cardiol 2015; 15: 970-975
    PubMedSearch in Google Scholar
  • 46 Joseph G, Zhao Y, Klaus W. Pharmacologic action profile of crataegus extract in comparison to epinephrine, amirinone, milrinone and digoxin in the isolated perfused guinea pig heart. Arzneimittelforschung 1995; 45: 1261-1265
    PubMedSearch in Google Scholar
  • 47 Müller A, Linke W, Klaus W.. Crataegus extract blocks potassium currents in guinea pig ventricular cardiac myocytes. Planta Med 1999; 65: 335-339
    PubMedSearch in Google Scholar
  • 48 Pöpping S, Rose H, Ionescu I. et al Effect of a hawthorn extract on contraction and energy turnover of isolated rat cardiomyocytes. Arzneimittelforschung 1995; 45: 1157-1161
    PubMedSearch in Google Scholar
  • 49 Rieckeheer E, Schwinger RH, Bloch W. et al Hawthorn special extract WS 1442 increases red blood cell NO-formation without altering red blood cell deformability. Phytomedicine 2011; 19: 20-24
    PubMedSearch in Google Scholar
  • 50 Hu YF, Chen YJ, Lin YJ. et al Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol 2015; 12: 230-243
    PubMedSearch in Google Scholar
  • 51 Van Wagoner DR.. Oxidative stress and inflammation in atrial fibrillation: Role in pathogenesis and potential as a therapeutic target. J Cardiovasc Pharmacol 2008; 52: 306-313
    CrossrefPubMedSearch in Google Scholar
  • 52 Koller M. Weißdorn-Spezialextrakt in der Therapie früher Stadien der KHK-assoziierten Herzinsuffizienz. Ergebnisse einer prospektiven Kohortenstudie zur Wirtschaftlichkeit und zum Einfluss auf die Lebensqualität der Patienten. MMW Fortschr Med 2005; 147: 159-164
    Search in Google Scholar
  • 53 Holubarsch CJF, Colucci WS, Meinertz T. The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: The SPICE trial. Eur J Heart Fail 2008; 10: 1255-1263
    PubMedSearch in Google Scholar
  • 54 Wyss C, Gündling PW, Kostev K.. Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany. Sci Rep 2024; 14 (01) 22986
    PubMedSearch in Google Scholar
  • 55 Weglicki W, Quamme G, Tucker K. et al Potassium, magnesium, and electrolyte imbalance and complications in disease management. Clin Exp Hypertens 2005; 27: 95-112
    PubMedSearch in Google Scholar
  • 56 Naveed M, Wenhua L, Gang W. et al A novel ventricular restraint device (ASD) repetitively deliver Salvia miltiorrhiza to epicardium have good curative effects in heart failure management. Biomed Pharmacother 2017; 95: 701-710
    PubMedSearch in Google Scholar
  • 57 Tauchert M, Gildor A, Lipinski J. Einsatz des hochdosierten Crataegusextraktes WS 1442 in der Therapie der Herzinsuffizienz Stadium NYHA II. Herz 1999; 24: 465-474
    PubMedSearch in Google Scholar
  • 58 Tauchert M. Efficacy and safety of crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class III heart failure. Am Heart J 2002; 143: 910-915
    PubMedSearch in Google Scholar
  • 59 Zick SM, Vautaw BM, Gillespie B. et al Hawthorn extract randomized blinded chronic heart failure (HERBCHF) trial. Eur J Heart Fail 2009; 11: 990-999
    PubMedSearch in Google Scholar